miR-875-5p counteracts epithelial-to-mesenchymal transition and enhances radiation response in prostate cancer through repression of the EGFR-ZEB1 axis
Rihan El Bezawy(Fondazione IRCCS Istituto Nazionale dei Tumori), Paolo Gandellini(University of Milan), Nicola Fenderico(University Medical Center Utrecht), Denis Cominetti(Fondazione IRCCS Istituto Nazionale dei Tumori), C. Stucchi(Fondazione IRCCS Istituto Nazionale dei Tumori), T. Rancati(Fondazione IRCCS Istituto Nazionale dei Tumori), Matteo Dugo(Fondazione IRCCS Istituto Nazionale dei Tumori), Noemi Arrighetti(Fondazione IRCCS Istituto Nazionale dei Tumori), Valentina Zuco(Fondazione IRCCS Istituto Nazionale dei Tumori), R. Valdagni, Nadia Zaffaroni(Fondazione IRCCS Istituto Nazionale dei Tumori), Giovanni Luca Beretta(Fondazione IRCCS Istituto Nazionale dei Tumori)
Cited by 96
Related Papers
Isolation and <i>In vitro</i> Propagation of Tumorigenic Breast Cancer Cells with Stem/Progenitor Cell Properties
|Cancer Research|2005|1.7k
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-term<i>In vitro</i>Culture and Do Not Exhibit Telomere Maintenance Mechanisms
|Cancer Research|2007|702
miR-205 Exerts Tumor-Suppressive Functions in Human Prostate through Down-regulation of Protein Kinase Cε
|Cancer Research|2009|363
Rational design of shepherdin, a novel anticancer agent
|Cancer Cell|2005|348
Exosome-mediated delivery of miR-9 induces cancer-associated fibroblast-like properties in human breast fibroblasts
|Cell Death and Disease|2016|302